Hinova Pharmaceuticals (SHSE:688302) FCF Yield % : -13.34 (As of Jun. 22, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Hinova Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Hinova Pharmaceuticals's Trailing 12-Month Free Cash Flow is ¥-357.29 Mil, and Market Cap is ¥2,678.37 Mil. Therefore, Hinova Pharmaceuticals's FCF Yield % for today is -13.34%.

The historical rank and industry rank for Hinova Pharmaceuticals's FCF Yield % or its related term are showing as below:

SHSE:688302' s FCF Yield % Range Over the Past 10 Years
Min: -17.54 Med: -8.93 Max: -5.12
Current: -13.34

During the past 6 years, the highest FCF Yield % of Hinova Pharmaceuticals was -5.12%. The lowest was -17.54%. And the median was -8.93%.

SHSE:688302's FCF Yield % is ranked better than
52.06% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs SHSE:688302: -13.34

Hinova Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Hinova Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Hinova Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hinova Pharmaceuticals FCF Yield % Chart

Hinova Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-9.62

-6.88

Hinova Pharmaceuticals Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial												-6.36	-7.62	-8.46	-5.97	-11.48

Competitive Comparison of Hinova Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Hinova Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hinova Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hinova Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Hinova Pharmaceuticals's FCF Yield % falls into.

Hinova Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Hinova Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-354.683	/	5155.742292
	=	-6.88%

Hinova Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-87.553	*	4	/	3051.660792
	=	-11.48%

Hinova Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Hinova Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Hinova Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hinova Pharmaceuticals (SHSE:688302) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hinova Pharmaceuticals Inc (SHSE:688302) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Keyuan South Road, No. 2 and 3, 4th Floor, Building 1, Rongyao Building, High-tech Zone, Sichuan Province, Chengdu, CHN, 610041

Website

http://www.hinovapharma.com

Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.

Hinova Pharmaceuticals (SHSE:688302) Headlines

No Headlines